- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Benevolentai S.A.
Headquarters: London, United Kingdom
Website: https://www.benevolent.com/
Year Founded: 2013
Status: Public
Industry Sector: HealthTechnology
CEO: Joerg Moeller, MD, PhD
Number Of Employees: 248
Enterprise Value: $54,214,528
PE Ratio: -0.17
Exchange/Ticker 1: Euronext Amsterdam:BAI
Exchange/Ticker 2: N/A
Latest Market Cap: $11,020,659
BioCentury | Feb 11, 2025
Management Tracks
Ideaya hires J.P. Morgan veteran Joshua Bleharski as CFO
Plus: Winselow Tucker named president of Lilly India, and updates from Santhera, Aurion and Oncolytics
BioCentury | Dec 13, 2024
Management Tracks
Genesis hires Shifeng Pan as CSO, names Paul Friedman chair
Plus: Gen1E names François Nader chairman, and updates from Iambic and Boundless
BioCentury | Oct 18, 2024
Management Tracks
Co-founders Mulvaney, Brennan return to BenevolentAI as CEO Moeller departs
Plus: Sage downsizes and updates from Xaira, DNA Script, Renovaro, Achieve, Adverum and more
BioCentury | Sep 4, 2024
Discovery & Translation
Immunoproteomics upstage genomics in I&I target discovery
Back to School 2024 identifies the target classes emerging in inflammation and immunology, and the technologies used to find them
BioCentury | Sep 3, 2024
Discovery & Translation
Eyes on the target: Drug discovery’s new paradigm
Back to School 2024: Can biotech write a more successful playbook for translating from target to product?
BioCentury | Jul 3, 2024
Management Tracks
Dahan succeeds Saad as Alkeus CEO
Plus: Fox becomes interim CEO of Alphina and updates from Inovio and BenevolentAI
BioCentury | Apr 16, 2024
Management Tracks
Viatris hires Corinne Le Goff as commercial head
Plus: Exact, Obsidian name new CFOs and updates from Applied, Faron, Athira and more
BioCentury | Mar 21, 2024
Management Tracks
Novartis’ Hanekamp to lead commercial at BioNTech
Plus: New leaders for Bayer’s commercial team and updates from Intra-Cellular, Affyimmune, BenevolentAI, Bicycle and VolitionRx
BioCentury | Jan 25, 2024
Management Tracks
Moeller named CEO of BenevolentAI
Plus: new CFO at Orion and updates from Alkeus and Immorta
BioCentury | Nov 16, 2023
Deals
Asset marketplace 9xchange augments toolbox with PhaseV trial analytics
Second machine-learning partnership follows BenevolentAI deal in the spring
Items per page:
1 - 10 of 18